Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting (vol 11, pg 2749, 2016)

被引：0
|
作者：
Perrone, V
Sangiorgi, D.
Buda, S.
Degli Esposti, L.
机构：
来源：
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2017年 / 12卷
关键词：
D O I：
10.2147/COPD.S130231
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [1] Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
    Perrone, Valentina
    Sangiorgi, Diego
    Buda, Stefano
    Esposti, Luca Degli
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2749 - 2755
  • [2] Cost effectiveness of budesonide/formoterol vs fluticasone/salmeterol: Real-world effectiveness and safety in COPD
    Hedegaard, Morten
    Janson, Christer
    Lisspers, Karin
    Stallberg, Bjorn
    Johansson, Gunnar
    Jorgensen, Leif
    Larssen, Kjell
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] COST-EFFECTIVENESS OF BUDESONIDE/FORMOTEROL VERSUS FLUTICASONE/SALMETEROL BASED ON REAL-WORLD EFFECTIVENESS IN PATIENTS WITH COPD
    Hedegaard, M.
    Janson, C.
    Lisspers, K.
    Stallberg, B.
    Johansson, G.
    Jorgensen, L.
    Larsson, K.
    VALUE IN HEALTH, 2012, 15 (07) : A563 - A563
  • [4] COST EFFECTIVENESS OF BUDESONIDE/FORMOTEROL VERSUS FLUTICASONE/SALMETEROL FROM A SWEDISH HEALTH CARE PERSPECTIVE BASED ON REAL-WORLD EFFECTIVENESS AND SAFETY IN PATIENTS WITH COPD
    Hedegaard, M.
    Janson, C.
    Lisspers, K.
    Stallberg, B.
    Johansson, G.
    Jorgensen, L.
    Larsson, K.
    VALUE IN HEALTH, 2013, 16 (03) : A235 - A235
  • [5] COMPARATIVE EFFECTIVENESS OF FIXED-DOSE FLUTICASONE PROPIONATE/SALMETEROL AND BUDESONIDE/FORMOTEROL COMBINATIONS IN ASTHMA: A US DATABASE ANALYSIS
    Hamouda, Mohamed
    Hanania, Nicola A.
    Stanford, Richard H.
    Rendon, Adrian
    Gemicioglu, Bilun
    Fritscher, Leandro
    Boonsawat, Watchara
    Khan, Shireen Quli
    CHEST, 2024, 166 (04) : 6461A - 6462A
  • [6] Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
    Cope, Shannon
    Kraemer, Matthias
    Zhang, Jie
    Capkun-Niggli, Gorana
    Jansen, Jeroen P.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 7 : 415 - 420
  • [7] COST-EFFECTIVENESS ANALYSIS OF GLYCOPIRRONIUM VERSUS TIOTROPIUM AND FIXED-DOSE COMBINATIONS (FORMOTEROL/BUDESONIDE AND SALMETEROL/FLUTICASONE) FOR COPD IN THE COLOMBIAN HEALTH CARE SYSTEM
    Giraldo, L. F.
    Karpf Benavides, E.
    Kraemer, M.
    Thuresson, P. O.
    VALUE IN HEALTH, 2014, 17 (03) : A175 - A175
  • [8] Effectiveness and Treatment Compliance of Salmeterol–Fluticasone Easyhaler® Among Patients with Asthma, COPD, or Asthma–COPD Overlap Syndrome: Real-World Study Findings
    Lilla Tamási
    Anna Bartha
    Aranka Ferencz
    Mihály Tímár
    Mikko Vahteristo
    Aino Takala
    Veronika Müller
    Pulmonary Therapy, 2022, 8 : 369 - 384
  • [9] First Real-World Evidence on budesonide/glycopyrronium/formoterol fumarate (BGF) use for COPD patients in France (ENARXI study): an interim analysis
    Deslee, Gaetan
    Poccardi, Nolwenn
    Fabry-Vendrand, Caroline
    Leynaud, Delphine
    Thabut, Gabriel
    Eteve-Pitsaer, Caroline
    Coriat, Adrien
    Ghout, Idir
    Leleu, Henri
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [10] Real-world outcomes of Budesonide/Glycopyrronium/Formoterol therapy in COPD after 3 months; Interim analysis of the RECORD study
    Watz, Henrik
    Halbach, Marija
    Saathoff, Matthias
    Morris, Tamsin
    Watt, Michael
    Milano, Annika Fernandez
    Shrikrishna, Dinesh
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345